NO972486L - Vedvarende frigjöring av legemiddel ved anvendelse av en pulverisert hydrokolloid-gummi som kan oppnås fra höyere planter - Google Patents
Vedvarende frigjöring av legemiddel ved anvendelse av en pulverisert hydrokolloid-gummi som kan oppnås fra höyere planterInfo
- Publication number
- NO972486L NO972486L NO972486A NO972486A NO972486L NO 972486 L NO972486 L NO 972486L NO 972486 A NO972486 A NO 972486A NO 972486 A NO972486 A NO 972486A NO 972486 L NO972486 L NO 972486L
- Authority
- NO
- Norway
- Prior art keywords
- higher plants
- drug release
- hydrocolloid gum
- drug
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Abstract
En farmasøytisk sammensetning som tilføres gjennom munnen for å oppnå vedvarende frigjøring av et legemiddel i et pattedyr. Sammensetningen omfatter (a) en egnet mengde av en farmasøytisk godtagbar hydrokolloid-gummi som kan oppnås fra høyere planter (f eks. omkring 20% til 90 vekt%), (b) en annen eksipient (f eks. omkring 5% til 30 vekt%) som bidrar til vedvarende frigjøring og (c) en terapeutisk effektiv mengde av et legemiddel. Det er foretrukket at gjermomsninlig panikkelstorrelse av gummien er omkring 150 \x eller mindre. Omfattet er også en fremgangsmåte for å fremstille sammensetningen og en metode for å oppnå vedvarende frigjoring av et legemiddel ved å tilfore sammensetningen til et tilfelle som har behov for dene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34851594A | 1994-12-01 | 1994-12-01 | |
PCT/US1995/015593 WO1996016638A1 (en) | 1994-12-01 | 1995-11-30 | Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants |
Publications (2)
Publication Number | Publication Date |
---|---|
NO972486D0 NO972486D0 (no) | 1997-05-30 |
NO972486L true NO972486L (no) | 1997-07-31 |
Family
ID=23368363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972486A NO972486L (no) | 1994-12-01 | 1997-05-30 | Vedvarende frigjöring av legemiddel ved anvendelse av en pulverisert hydrokolloid-gummi som kan oppnås fra höyere planter |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0793485A4 (no) |
JP (1) | JPH10509981A (no) |
CN (1) | CN1172429A (no) |
AU (1) | AU709413B2 (no) |
CA (1) | CA2205351A1 (no) |
FI (1) | FI972304A (no) |
MX (1) | MX9704043A (no) |
NO (1) | NO972486L (no) |
WO (1) | WO1996016638A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
IL119627A (en) * | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
US6210710B1 (en) * | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
EP0987020A1 (en) * | 1998-09-04 | 2000-03-22 | Pharma Pass LLC | Metoprolol composition and processes for manufacturing the same |
EP0974343B1 (en) * | 1998-07-22 | 2004-09-29 | Pharma Pass II LLC | Process for manufacturing a solid metoprolol composition |
SE0003125D0 (sv) * | 2000-09-05 | 2000-09-05 | Astrazeneca Ab | Modified polymers |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1327938A (en) * | 1969-12-17 | 1973-08-22 | Sucrest Corp | Composition for use in forming tablets |
DE2130545A1 (de) * | 1971-06-19 | 1972-12-21 | Merck Patent Gmbh | Pharmazeutischer Formkoerper |
CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
DK130287D0 (da) * | 1987-03-13 | 1987-03-13 | Benzon As Alfred | Oralt praeparat |
US5169639A (en) * | 1988-09-19 | 1992-12-08 | Edward Mendell Co., Inc. | Controlled release verapamil tablets |
JP2628231B2 (ja) * | 1992-12-30 | 1997-07-09 | エフ エム シー コーポレーション | 放出調整賦形剤として容易に入手できるコンニャクグルコマンナン |
-
1995
- 1995-11-30 WO PCT/US1995/015593 patent/WO1996016638A1/en not_active Application Discontinuation
- 1995-11-30 CN CN 95197093 patent/CN1172429A/zh active Pending
- 1995-11-30 EP EP95942521A patent/EP0793485A4/en not_active Withdrawn
- 1995-11-30 JP JP8519073A patent/JPH10509981A/ja active Pending
- 1995-11-30 AU AU43720/96A patent/AU709413B2/en not_active Ceased
- 1995-11-30 CA CA 2205351 patent/CA2205351A1/en not_active Abandoned
- 1995-11-30 MX MX9704043A patent/MX9704043A/es unknown
-
1997
- 1997-05-30 FI FI972304A patent/FI972304A/fi unknown
- 1997-05-30 NO NO972486A patent/NO972486L/no unknown
Also Published As
Publication number | Publication date |
---|---|
MX9704043A (es) | 1998-02-28 |
AU4372096A (en) | 1996-06-19 |
EP0793485A1 (en) | 1997-09-10 |
EP0793485A4 (en) | 1998-08-26 |
AU709413B2 (en) | 1999-08-26 |
CA2205351A1 (en) | 1996-06-06 |
CN1172429A (zh) | 1998-02-04 |
WO1996016638A1 (en) | 1996-06-06 |
JPH10509981A (ja) | 1998-09-29 |
NO972486D0 (no) | 1997-05-30 |
FI972304A0 (fi) | 1997-05-30 |
FI972304A (fi) | 1997-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0831791T3 (da) | Transport af lægemiddelstoffer til den nedre gastrointestinalkanal | |
FI935847A (fi) | L-DOPA-esterikoostumukset | |
ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
IT1282352B1 (it) | Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per | |
IS4187A (is) | Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun | |
DK0923934T3 (da) | Modified release-matrixformulering af cefaclor og cephalexin | |
CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
MY125662A (en) | Pharmaceutical formulations containing darifenacin | |
ES2151083T3 (es) | Composiciones orales que contienen ondansetron. | |
NO307594B1 (no) | Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat | |
CA2136404A1 (fr) | Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale | |
RU2003100507A (ru) | Фармацевтические композиции | |
NO972486L (no) | Vedvarende frigjöring av legemiddel ved anvendelse av en pulverisert hydrokolloid-gummi som kan oppnås fra höyere planter | |
NO962752L (no) | Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose | |
NO972485L (no) | NSAID frigjöring ved anvendelse av en pulverisert hydrokolloid-gummi som kan oppnås fra höyere planter | |
WO2001093850B1 (en) | Methods and compositions using sulodexide for the treatment of diabetic nephropathy | |
NO20032581L (no) | Farmasöytisk formulering av gepiron for oral administrering | |
Park | The Effects of Methylprednisolone on Prevention of Brain Edema after Experimental Moderate Diffuse Brain Injury in Rats | |
ECSP993133A (es) | Nueva composicion oral compactada que comprende derivados de catecol | |
CO5150206A1 (es) | Metodo para la prevencion o reduccion de episodios cardiovasculares asociados con intervenciones coronarias |